| CASE REPORT |
|
| Year : 2022 | Volume
: 9
| Issue : 2 | Page : 72-76 |
|
|
Human immunodeficiency virus-associated dementia: Two case reports
Nefise Eda Arslanoglu, Nazli Gamze Bülbül, Mehmet Güney Senol, Mehmet Fatih Özdag
Department of Neurology, Sultan Abdülhamid Han Research and Training Hospital, Istanbul, Turkey
Correspondence Address:
Nefise Eda Arslanoglu
Department of Neurology, Sultan Abdülhamid Han Research and Training Hospital, Istanbul
Turkey
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/jnbs.jnbs_22_22
|
|
|
Human immunodeficiency virus (HIV) continues to be a serious public health problem in our country in the world and has serious effects on the central and peripheral nervous system. HIV-associated dementia (HAD), which may develop due to HIV infection, causes subcortical dementia that can progress with marked slowdown in reaction time and psychomotor speed, impaired cognitive flexibility, emotional lability, and apathy. Neurocognitive tests are the most appropriate tools for the neurocognitive assessment and staging of the disease. In this context, the Addenbrooke's Cognitive Examinations Revised (ACE-R) test may be preferred in the neurocognitive evaluation of patients considered to have HAD, in terms of its repeatability and easy applicability, as it allows us to evaluate many neurocognitive functions in detail.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
